Stock-Based Compensation | Stock-Based Compensation The Company has outstanding equity awards under various plans, as described below. Datto 2020 Omnibus Incentive Plan In conjunction with the IPO, on October 20, 2020, the Board adopted the Datto Holding Corp. Omnibus Incentive Plan (the “2020 Plan”) in order to align the interests of the participants with the interests of the Company's stockholders. The 2020 Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units ("RSUs"), bonus stock, dividend equivalents, other stock-based awards, substitute awards, annual incentive awards and performance awards to employees, consultants, and members of the Board. Authorized shares under the 2020 Plan automatically increase each January 1 by 5% of the outstanding number of shares of the Company's common stock on the immediately preceding December 31st, or such lesser number of shares as determined by the Board. See below for a reconciliation of shares of the Company’s common stock reserved for issuance under the 2020 Plan. Under the 2020 Plan, 919,775 RSUs and 10,000 stock options were outstanding as of March 31, 2021. 2017 Stock Option Plan In December 2017, the Company adopted the 2017 Stock Option Plan (the “2017 Plan”), as amended, which provides for grants of stock options to employees, directors, officers, and consultants. As of March 31, 2021, 9,089,564 stock options were outstanding under the 2017 Plan. No additional awards may be issued under the 2017 Plan. Other Equity Plans The Company also has outstanding options which were issued under the Autotask Superior Holdings 2013 Stock Option Plan (the “Autotask Plan”). As of March 31, 2021, 375,623 fully-vested stock options were outstanding under the Autotask Plan. No additional awards may be issued under the Autotask Plan. In addition, the Company has two other plans, which were adopted in relation to grants to independent members of the Board, prior to the adoption of the 2020 Plan. As of March 31, 2021, 23,438 RSUs were outstanding and no additional awards may be issued under these plans. Stock Options The following table summarizes stock option activity related to all plans during the three months ended March 31, 2021 (in thousands, except share and per share amounts): Number of Weighted Weighted Aggregate Options outstanding at December 31, 2020 9,555,082 $ 10.49 7.5 $ 157,800 Options granted 10,000 $ 25.23 Options exercised (19,476) $ 8.64 Options forfeited & expired (70,419) $ 11.33 Options outstanding at March 31, 2021 9,475,187 $ 10.50 7.7 $ 117,627 Options vested and exercisable at March 31, 2021 5,029,283 $ 9.87 7.3 $ 65,595 The aggregate intrinsic value of stock options exercised during the three months ended March 31, 2021 and 2020 was $0.3 million and $1.2 million, respectively. The weighted average fair value of options granted to purchase common stock during the three months ended March 31, 2021 was $14.83. As of March 31, 2021, unrecognized compensation expense related to outstanding stock options was $41.8 million, which is expected to be recognized over the remaining weighted average term of 2.0 years. Restricted Stock Units The following table summarizes RSU activity under all plans during the three months ended March 31, 2021: Number of Weighted RSUs outstanding at December 31, 2020 696,338 $ 26.73 RSUs granted 253,050 $ 25.23 RSUs vested (2,675) $ 26.70 RSUs forfeited (3,500) $ 26.36 RSUs outstanding at March 31, 2021 943,213 $ 26.33 As of March 31, 2021, unrecognized compensation expense related to outstanding RSUs was $22.4 million, which is expected to be recognized over the remaining weighted average term of 3.6 years. Shares Available for Future Grants The following table summarizes the shares available for future grants under the 2020 Plan: Shares Balance at December 31, 2020 20,195,974 Annual authorization increase 8,071,001 Options and RSUs granted (263,050) Options and RSUs forfeited or expired 4,384 Balance at March 31, 2021 28,008,309 Stock-Based Compensation Expense Stock-based compensation expense for the three months ended March 31, 2021 and 2020 was as follows (in thousands): Three Months Ended March 31, 2021 2020 Cost of revenue—subscription $ 1,228 $ 20 Cost of revenue—device 62 — Cost of revenue—professional services and other 103 — Sales and marketing 2,295 644 Research and development 4,874 310 General and administrative 2,949 940 Total stock-based compensation expense $ 11,511 $ 1,914 |